Advertisement

Advertisement

COLL Stock Latest News

Collegium Pharma Leans on ADHD to Drive Growth

Company AnnouncementsCollegium Pharma Leans on ADHD to Drive Growth

Collegium Shareholders Back Board, Pay and Auditor Choices

PremiumCompany Announcements

Collegium Shareholders Back Board, Pay and Auditor Choices

18d ago

Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition

PremiumCompany Announcements

Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition

22d ago

Collegium Pharmaceutical Leans Into Growth After Earnings

PremiumCompany Announcements

Collegium Pharmaceutical Leans Into Growth After Earnings

26d ago

Collegium Reports Strong Q1 Results, Reaffirms 2026 Outlook

PremiumCompany Announcements

Collegium Reports Strong Q1 Results, Reaffirms 2026 Outlook

26d ago

Collegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52

PremiumThe FlyCollegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52

27d ago

Collegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M

The Fly

Collegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M

27d ago

Confident Leadership and Attractive Valuation Drive Buy Rating on Collegium (COLL)

Ratings

Confident Leadership and Attractive Valuation Drive Buy Rating on Collegium (COLL)

2M ago

Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating

PremiumRatings

Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating

2M ago

Collegium Pharmaceutical to Acquire AZSTARYS ADHD Franchise

PremiumCompany Announcements

Collegium Pharmaceutical to Acquire AZSTARYS ADHD Franchise

3M ago

Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash

PremiumThe Fly

Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash

3M ago

Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign

PremiumThe Fly

Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign

3M ago

Collegium Pharmaceutical Earnings Call: Jornay Leads Growth

PremiumCompany AnnouncementsCollegium Pharmaceutical Earnings Call: Jornay Leads Growth

3M ago

Collegium Reports Record 2025 Results and Reaffirms Outlook

Company Announcements

Collegium Reports Record 2025 Results and Reaffirms Outlook

3M ago

Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14

The Fly

Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14

3M ago

Collegium Pharmaceutical sees FY26 product revenue $805M-$825M

PremiumThe Fly

Collegium Pharmaceutical sees FY26 product revenue $805M-$825M

3M ago

Collegium Pharmaceutical Inc. (COLL) Q4 Earnings Cheat Sheet

PremiumPre-Earnings

Collegium Pharmaceutical Inc. (COLL) Q4 Earnings Cheat Sheet

3M ago

Collegium Pharmaceutical enters multiyear partnership with Boston Legacy FC

PremiumThe Fly

Collegium Pharmaceutical enters multiyear partnership with Boston Legacy FC

3M ago

Collegium Pharmaceutical price target raised to $58 from $55 at Truist

PremiumThe Fly

Collegium Pharmaceutical price target raised to $58 from $55 at Truist

4M ago

Collegium Pharmaceutical management to meet with Truist

PremiumThe FlyCollegium Pharmaceutical management to meet with Truist

4M ago

Collegium price target lowered to $56 from $58 at Barclays

The Fly

Collegium price target lowered to $56 from $58 at Barclays

5M ago

Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright

The Fly

Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >